A generally accepted definition of high myopia is needed.
Individual interventions may not result in the expected efficacy.
Results of a single masked, randomized two-year controlled clinical trial
The OCULUS Myopia Master® is the world’s first device to combine all the important measurements for myopia management.
The real value of this study, however, lies in the follow-up findings after cessation of the outdoor intervention.
Practitioners offering myopia management need to know the effect a patient’s binocular vision status has on their management strategies.
The authors suggest the need for more rigorous clinical trials.
Combined interventions for myopia will potentially influence the standard of care.
Existing evidence has failed to convince doctors to uniformly embrace treatments for myopic progression control.
Does planning extra time outdoors during the school day help?
It has been said that nearly one-third to one-half fail to comply with general medical advice and prescriptions.
A summary of the LAMP Study results
Axial elongation rate is faster in younger children undergoing ortho-k treatment.
When should one start atropine treatment for myopes?